Copyright Reports & Markets. All rights reserved.

Global Human Procalcitonin Recombinant Protein Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Human Procalcitonin Recombinant Protein by Type
    • 1.3.1 Overview: Global Human Procalcitonin Recombinant Protein Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Human Procalcitonin Recombinant Protein Consumption Value Market Share by Type in 2025
    • 1.3.3 Purity>90%
    • 1.3.4 Purity>95%
    • 1.3.5 Others
  • 1.4 Global Human Procalcitonin Recombinant Protein Market by Application
    • 1.4.1 Overview: Global Human Procalcitonin Recombinant Protein Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Clinical Diagnosis
    • 1.4.3 Scientific Research
    • 1.4.4 Drug Development
    • 1.4.5 Others
  • 1.5 Global Human Procalcitonin Recombinant Protein Market Size & Forecast
  • 1.6 Global Human Procalcitonin Recombinant Protein Market Size and Forecast by Region
    • 1.6.1 Global Human Procalcitonin Recombinant Protein Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Human Procalcitonin Recombinant Protein Market Size by Region, (2021-2032)
    • 1.6.3 North America Human Procalcitonin Recombinant Protein Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Human Procalcitonin Recombinant Protein Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Human Procalcitonin Recombinant Protein Market Size and Prospect (2021-2032)
    • 1.6.6 South America Human Procalcitonin Recombinant Protein Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Human Procalcitonin Recombinant Protein Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Thermo Fisher
    • 2.1.1 Thermo Fisher Details
    • 2.1.2 Thermo Fisher Major Business
    • 2.1.3 Thermo Fisher Human Procalcitonin Recombinant Protein Product and Solutions
    • 2.1.4 Thermo Fisher Human Procalcitonin Recombinant Protein Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Thermo Fisher Recent Developments and Future Plans
  • 2.2 Abnova
    • 2.2.1 Abnova Details
    • 2.2.2 Abnova Major Business
    • 2.2.3 Abnova Human Procalcitonin Recombinant Protein Product and Solutions
    • 2.2.4 Abnova Human Procalcitonin Recombinant Protein Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Abnova Recent Developments and Future Plans
  • 2.3 HyTest
    • 2.3.1 HyTest Details
    • 2.3.2 HyTest Major Business
    • 2.3.3 HyTest Human Procalcitonin Recombinant Protein Product and Solutions
    • 2.3.4 HyTest Human Procalcitonin Recombinant Protein Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 HyTest Recent Developments and Future Plans
  • 2.4 Abcam
    • 2.4.1 Abcam Details
    • 2.4.2 Abcam Major Business
    • 2.4.3 Abcam Human Procalcitonin Recombinant Protein Product and Solutions
    • 2.4.4 Abcam Human Procalcitonin Recombinant Protein Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Abcam Recent Developments and Future Plans
  • 2.5 R&D Systems
    • 2.5.1 R&D Systems Details
    • 2.5.2 R&D Systems Major Business
    • 2.5.3 R&D Systems Human Procalcitonin Recombinant Protein Product and Solutions
    • 2.5.4 R&D Systems Human Procalcitonin Recombinant Protein Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 R&D Systems Recent Developments and Future Plans
  • 2.6 ProSpec
    • 2.6.1 ProSpec Details
    • 2.6.2 ProSpec Major Business
    • 2.6.3 ProSpec Human Procalcitonin Recombinant Protein Product and Solutions
    • 2.6.4 ProSpec Human Procalcitonin Recombinant Protein Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 ProSpec Recent Developments and Future Plans
  • 2.7 RayBiotech
    • 2.7.1 RayBiotech Details
    • 2.7.2 RayBiotech Major Business
    • 2.7.3 RayBiotech Human Procalcitonin Recombinant Protein Product and Solutions
    • 2.7.4 RayBiotech Human Procalcitonin Recombinant Protein Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 RayBiotech Recent Developments and Future Plans
  • 2.8 Novus Biological
    • 2.8.1 Novus Biological Details
    • 2.8.2 Novus Biological Major Business
    • 2.8.3 Novus Biological Human Procalcitonin Recombinant Protein Product and Solutions
    • 2.8.4 Novus Biological Human Procalcitonin Recombinant Protein Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Novus Biological Recent Developments and Future Plans
  • 2.9 Sino Biological
    • 2.9.1 Sino Biological Details
    • 2.9.2 Sino Biological Major Business
    • 2.9.3 Sino Biological Human Procalcitonin Recombinant Protein Product and Solutions
    • 2.9.4 Sino Biological Human Procalcitonin Recombinant Protein Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Sino Biological Recent Developments and Future Plans
  • 2.10 BioVendor
    • 2.10.1 BioVendor Details
    • 2.10.2 BioVendor Major Business
    • 2.10.3 BioVendor Human Procalcitonin Recombinant Protein Product and Solutions
    • 2.10.4 BioVendor Human Procalcitonin Recombinant Protein Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 BioVendor Recent Developments and Future Plans
  • 2.11 Assay Genie
    • 2.11.1 Assay Genie Details
    • 2.11.2 Assay Genie Major Business
    • 2.11.3 Assay Genie Human Procalcitonin Recombinant Protein Product and Solutions
    • 2.11.4 Assay Genie Human Procalcitonin Recombinant Protein Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Assay Genie Recent Developments and Future Plans
  • 2.12 Bioss Antibodies
    • 2.12.1 Bioss Antibodies Details
    • 2.12.2 Bioss Antibodies Major Business
    • 2.12.3 Bioss Antibodies Human Procalcitonin Recombinant Protein Product and Solutions
    • 2.12.4 Bioss Antibodies Human Procalcitonin Recombinant Protein Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Bioss Antibodies Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Human Procalcitonin Recombinant Protein Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Human Procalcitonin Recombinant Protein by Company Revenue
    • 3.2.2 Top 3 Human Procalcitonin Recombinant Protein Players Market Share in 2025
    • 3.2.3 Top 6 Human Procalcitonin Recombinant Protein Players Market Share in 2025
  • 3.3 Human Procalcitonin Recombinant Protein Market: Overall Company Footprint Analysis
    • 3.3.1 Human Procalcitonin Recombinant Protein Market: Region Footprint
    • 3.3.2 Human Procalcitonin Recombinant Protein Market: Company Product Type Footprint
    • 3.3.3 Human Procalcitonin Recombinant Protein Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Human Procalcitonin Recombinant Protein Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Human Procalcitonin Recombinant Protein Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Human Procalcitonin Recombinant Protein Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Human Procalcitonin Recombinant Protein Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Human Procalcitonin Recombinant Protein Consumption Value by Type (2021-2032)
  • 6.2 North America Human Procalcitonin Recombinant Protein Market Size by Application (2021-2032)
  • 6.3 North America Human Procalcitonin Recombinant Protein Market Size by Country
    • 6.3.1 North America Human Procalcitonin Recombinant Protein Consumption Value by Country (2021-2032)
    • 6.3.2 United States Human Procalcitonin Recombinant Protein Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Human Procalcitonin Recombinant Protein Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Human Procalcitonin Recombinant Protein Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Human Procalcitonin Recombinant Protein Consumption Value by Type (2021-2032)
  • 7.2 Europe Human Procalcitonin Recombinant Protein Consumption Value by Application (2021-2032)
  • 7.3 Europe Human Procalcitonin Recombinant Protein Market Size by Country
    • 7.3.1 Europe Human Procalcitonin Recombinant Protein Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Human Procalcitonin Recombinant Protein Market Size and Forecast (2021-2032)
    • 7.3.3 France Human Procalcitonin Recombinant Protein Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Human Procalcitonin Recombinant Protein Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Human Procalcitonin Recombinant Protein Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Human Procalcitonin Recombinant Protein Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Human Procalcitonin Recombinant Protein Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Human Procalcitonin Recombinant Protein Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Human Procalcitonin Recombinant Protein Market Size by Region
    • 8.3.1 Asia-Pacific Human Procalcitonin Recombinant Protein Consumption Value by Region (2021-2032)
    • 8.3.2 China Human Procalcitonin Recombinant Protein Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Human Procalcitonin Recombinant Protein Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Human Procalcitonin Recombinant Protein Market Size and Forecast (2021-2032)
    • 8.3.5 India Human Procalcitonin Recombinant Protein Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Human Procalcitonin Recombinant Protein Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Human Procalcitonin Recombinant Protein Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Human Procalcitonin Recombinant Protein Consumption Value by Type (2021-2032)
  • 9.2 South America Human Procalcitonin Recombinant Protein Consumption Value by Application (2021-2032)
  • 9.3 South America Human Procalcitonin Recombinant Protein Market Size by Country
    • 9.3.1 South America Human Procalcitonin Recombinant Protein Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Human Procalcitonin Recombinant Protein Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Human Procalcitonin Recombinant Protein Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Human Procalcitonin Recombinant Protein Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Human Procalcitonin Recombinant Protein Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Human Procalcitonin Recombinant Protein Market Size by Country
    • 10.3.1 Middle East & Africa Human Procalcitonin Recombinant Protein Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Human Procalcitonin Recombinant Protein Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Human Procalcitonin Recombinant Protein Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Human Procalcitonin Recombinant Protein Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Human Procalcitonin Recombinant Protein Market Drivers
  • 11.2 Human Procalcitonin Recombinant Protein Market Restraints
  • 11.3 Human Procalcitonin Recombinant Protein Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Human Procalcitonin Recombinant Protein Industry Chain
  • 12.2 Human Procalcitonin Recombinant Protein Upstream Analysis
  • 12.3 Human Procalcitonin Recombinant Protein Midstream Analysis
  • 12.4 Human Procalcitonin Recombinant Protein Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Human Procalcitonin Recombinant Protein market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Human Procalcitonin Recombinant Protein is a human procalcitonin protein expressed and purified in vitro by genetic engineering technology. Procalcitonin (PCT) is a protein that is significantly elevated during bacterial infection and systemic inflammatory response and is an important marker of infection and inflammation. Recombinant procalcitonin protein is used for research, diagnostic and therapeutic applications, providing high purity and high activity protein.
    This report is a detailed and comprehensive analysis for global Human Procalcitonin Recombinant Protein market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Human Procalcitonin Recombinant Protein market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Human Procalcitonin Recombinant Protein market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Human Procalcitonin Recombinant Protein market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Human Procalcitonin Recombinant Protein market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Human Procalcitonin Recombinant Protein
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Human Procalcitonin Recombinant Protein market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, Abnova, HyTest, Abcam, R&D Systems, ProSpec, RayBiotech, Novus Biological, Sino Biological, BioVendor, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Human Procalcitonin Recombinant Protein market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Purity>90%
    Purity>95%
    Others
    Market segment by Application
    Clinical Diagnosis
    Scientific Research
    Drug Development
    Others
    Market segment by players, this report covers
    Thermo Fisher
    Abnova
    HyTest
    Abcam
    R&D Systems
    ProSpec
    RayBiotech
    Novus Biological
    Sino Biological
    BioVendor
    Assay Genie
    Bioss Antibodies
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Human Procalcitonin Recombinant Protein product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Human Procalcitonin Recombinant Protein, with revenue, gross margin, and global market share of Human Procalcitonin Recombinant Protein from 2021 to 2026.
    Chapter 3, the Human Procalcitonin Recombinant Protein competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Human Procalcitonin Recombinant Protein market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Human Procalcitonin Recombinant Protein.
    Chapter 13, to describe Human Procalcitonin Recombinant Protein research findings and conclusion.

    Buy now